Cargando…
Genetic and Pharmacological Inhibition of GCN2 Ameliorates Hyperglycemia and Insulin Resistance in Type 2 Diabetic Mice
It is well recognized that there is a strong and complex association between nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D). We previously demonstrated that genetic knockout or pharmacological inhibition of general control nondepressible kinase 2 (GCN2), a well-known amino acid s...
Autores principales: | Yuan, Juntao, Li, Fang, Shen, Xiyue, Gao, Junling, Yu, Zhuoran, Luo, Kai, Cui, Bingqing, Lu, Zhongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404927/ https://www.ncbi.nlm.nih.gov/pubmed/36009303 http://dx.doi.org/10.3390/antiox11081584 |
Ejemplares similares
-
Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation
por: Yuan, Juntao, et al.
Publicado: (2021) -
Inhibition of GCN2 Alleviates Cardiomyopathy in Type 2 Diabetic Mice via Attenuating Lipotoxicity and Oxidative Stress
por: Yuan, Juntao, et al.
Publicado: (2022) -
Hepatic DDAH1 mitigates hepatic steatosis and insulin resistance in obese mice: Involvement of reduced S100A11 expression
por: Shen, Xiyue, et al.
Publicado: (2023) -
GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress
por: Wang, Yue, et al.
Publicado: (2018) -
Metformin protects against PM(2.5)-induced lung injury and cardiac dysfunction independent of AMP-activated protein kinase α2
por: Gao, Junling, et al.
Publicado: (2019)